Intuits Latest Earnings Test Morgan Stanleys Stock Forecast
Foreign Investors Offload Over Rs 30000 Crore in Indian Equities in May as 2026 Outflows Reach Rs 222 Lakh Crore
China Calls for APEC Cooperation as Commerce Minister Skips Opening Over Urgent Official Business
Pinterest Inc Analyst Report Suggests Potential Growth Amid Digital Ad Shifts
Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Mine
Lithuania Data Breach Compromises 600000 National Records Including Potential Spy Identities
ASP Isotopes Q4 2025 Earnings Widerthanexpected loss fails to dampen investor sentiment
SI Q1 2026 Earnings NarrowerThanExpected Loss Amid Operational Progress
KLAR Q1 2026 Earnings Net Loss Narrows Sharply Beating Estimates by Wide Margin
DLTH Q1 2026 Earnings EPS Surges Past Estimates Driving Shares Higher
PDEX Q1 2026 Earnings EPS Surges 8975 Above Estimates Amid Stock Decline
COYA Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Efficiency Gains
Cohen Steers Infrastructure Fund UTF Edges Higher as Infrastructure Demand Remains Steady
Newbury Street II Acquisition Corp Warrant NTWOW Holds Steady at 018 Amid Tight Trading Range
Draganfly DPRO Shares Edge Higher Support Tested as Drone Maker Eyes Resistance
Childrens Place PLCE Rallies 35 as Oversold Bounce Challenges Resistance Zone
Foremost Clean Energy Warrants Surge FMSTW Climbs Nearly 10 as Momentum Builds
USIran Standoff Deepens After Trump Rejects Counteroffer Raising Risks for Global Energy Markets
Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher
Pattern Group PTRN Surges 412 as Bulls Target Key Resistance
GigCapital9 Corp Rights GIXXR Hold Steady at 032 as Support and Resistance Levels Tighten
Psyence Biomedical Warrants PBMWW Edge Higher Support and Resistance Converge at 003
Anika Therapeutics Edges Higher as Stock Tests Key Resistance Zone
Polaryx Therapeutics PLYX Slips 863 as Biotech Volatility Resurfaces Key Support Levels in Focus
enGene Holdings Inc ENGN Gains 349 as Stock Approaches Key Resistance
Lexicon Pharmaceuticals LXRX Slides 314 as Shares Test NearTerm Support Levels
Enliven Therapeutics ELVN Faces Pressure as Shares Dip 168 Key Support Levels in Focus